I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 1 funding opportunity announcement (FOA) (PAR-22-250) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to establish a center of excellence that helps develop a critical mass of investigators and improve infrastructure in an area of biomedical research.
Application receipt date: January 30, 2023
Earliest start date: December 2023
We strongly encourage all potential Phase 1 COBRE applicants and institutional officials to attend our upcoming webinar:
Tuesday, September 27, 2:00-3:30 p.m. ET
Zoom Meeting link
Meeting ID: 161 965 8473
If you’re unable to attend online, you can join by calling 669-254-5252 or 551-285-1373 (United States) and entering the meeting ID and passcode.
During the webinar, we’ll present an overview of the COBRE Phase 1 program’s objectives and go over changes from the prior FOA, emphasizing eligibility and reporting requirements, and other key aspects of PAR-22-250. We’ll also answer your questions.
Participants are encouraged to submit questions prior to the webinar by contacting me no later than September 26. Those requiring sign language interpretation and/or other reasonable accommodations should use our contact form to request accommodations at least 5 days prior to the webinar.
The webinar and presentation slides will be posted on the COBRE webpage following the event.